Apogee Therapeutics (APGE) Change in Acquisitions & Divestments (2024 - 2026)

Apogee Therapeutics (APGE) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $147.9 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 28.05% year-over-year to $147.9 million in Q1 2026; TTM through Mar 2026 was $500.3 million, a 27.9% increase from a year earlier, with the FY2025 full-year figure at $467.9 million, up 33.62% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $147.9 million, up from $100.5 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for APGE reached as high as $147.9 million in Q1 2026 and fell as low as $74.5 million in Q1 2024.
• Historically, Change in Acquisitions & Divestments has averaged $107.3 million across 3 years, with a median of $107.0 million in 2024.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 61.25% in 2025 and fell as far as 6.01% in 2025.
• Year by year, Change in Acquisitions & Divestments stood at $107.0 million in 2024, then retreated by 6.01% to $100.5 million in 2025, then surged by 47.12% to $147.9 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $147.9 million in Q1 2026, $100.5 million in Q4 2025, and $125.6 million in Q3 2025.